Abstract
Purpose
Even though Kurdistan, the western province of Iran, has a cancer surveillance system, a detailed analysis of incidence rate has not been yet performed. We describe Age Standardized Incidence Rates (ASRs) for esophageal cancer (EC) in Kurdistan Province of Iran in 2001–2015.
Methods
Incidence cases of EC were obtained from a population-based cancer registry. We obtained ASRs and 95% confidence intervals (CI) per 100,000 populations for each calendar year group.
Results
Between 2001 and 2015, 1362 incidence cases with EC were reported to the cancer registry. Annual ASRs in 2006–2010 were more than the other years in both men and women, respectively. Most ASRs were reported among women in Divandarreh (18.95, 95% CI 14.76, 23.92), Saqez (12.75, 95% CI 10.73, 15.01), Sanandaj (8.84, 95% CI 7.64, 10.17), and Qorveh (8.19, 95% CI 6.54, 10.12), and among men in Divandarreh (19.38, 95% CI 15.38, 24.06), Saqez (13.64, 95% CI 11.49, 16.05), Sanandaj (8.70, 95% CI 7.56, 9.96), and Marivan (7.93, 95% CI 6.26, 9.88).
Conclusions
It was concluded that EC in Divandarreh, Saqez, and Sanandaj has the highest ASRs, and these areas are considered as high-risk areas for this disease in the Iranian province of Kurdistan. Therefore, to understand the reasons of these problems, a considerable work is needed.
Similar content being viewed by others
References
Lagergren J, Smyth E, Cunningham D, Lagergren P. Oesophageal cancer. Lancet. 2017; https://doi.org/10.1016/S0140-6736(17)31462-9.
Global Burden of Disease Cancer C. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524–48. https://doi.org/10.1001/jamaoncol.2016.5688.
Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet. 2013;381(9864):400–12. https://doi.org/10.1016/S0140-6736(12)60643-6.
Rice TW, Chen LQ, Hofstetter WL, Smithers BM, Rusch VW, Wijnhoven BPL, et al. Worldwide Esophageal Cancer Collaboration: pathologic staging data. Dis Esophagus. 2016;29(7):724–33. https://doi.org/10.1111/dote.12520.
Darabi M, Asadi Lari M, Motevalian SA, Motlagh A, Arsang-Jang S, Karimi Jaberi M. Trends in gastrointestinal cancer incidence in Iran, 2001-2010: a joinpoint analysis. Epidemiol Health. 2016;38:e2016056. https://doi.org/10.4178/epih.e2016056.
Naghibzadeh Tahami A, Khanjani N, Yazdi Feyzabadi V, Varzandeh M, Haghdoost A. Opium use as a risk factor for upper gastro-intestinal cancers: a population-based case control study in Iran. Arch Iran Med. 2014;17(1):2–6.
Ghasemi-Kebria F, Semnani S, Shakeri R, Khoshnia M, Naeimi-Tabiei M, Merat S, et al. Marked increase in the incidence rate of esophageal adenocarcinoma in a high-risk area for esophageal cancer. Arch Iran Med. 2013;16(6):320–3.
Haghdoost A, Hosseini H, Chamani G, Zarei M, Rad M, Hashemipoor M, et al. Rising incidence of adenocarcinoma of the esophagus in Kerman, Iran. Arch Iran Med. 2008;11(4):364–70.
Morris Brown L, Hoover R, Silverman D, Baris D, Hayes R, Swanson GM, et al. Excess incidence of squamous cell esophageal cancer among US black men: role of social class and other risk factors. Am J Epidemiol. 2001;153(2):114–22. https://doi.org/10.1093/aje/153.2.114.
Statistical Center of Iran Web Page (2017) https://www.amar.org.ir/english. https://www.amar.org.ir/english.
McGahan CE, Linn K, Guno P, Johnson H, Coldman AJ, Spinelli JJ, et al. Cancer in First Nations people living in British Columbia, Canada: an analysis of incidence and survival from 1993 to 2010. Cancer Causes Control. 2017;28(10):1105–16. https://doi.org/10.1007/s10552-017-0950-7.
Lehnert M, Kraywinkel K, Heinze E, Wiethege T, Johnen G, Fiebig J, et al. Incidence of malignant mesothelioma in Germany 2009–2013. Cancer Causes Control. 2017;28(2):97–105. https://doi.org/10.1007/s10552-016-0838-y.
Bray F, Ferlay J. Age standardization. In: Forman D, Bray F, Brewster DH, et al., editors. Cancer Incidence in Five Continents, vol X. Lyon: IARC Scientific Publication No. 164, International Agency for Research on Cancer; 2014.
Consonni D, Coviello E, Buzzoni C, Mensi C. A command to calculate age-standardized rates with efficient interval estimation. Stata J. 2012;12(4):688–701.
Lu C-L, Lang H-C, Luo J-C, Liu C-C, Lin H-C, Chang F-Y, et al. Increasing trend of the incidence of esophageal squamous cell carcinoma, but not adenocarcinoma, in Taiwan. Cancer Causes Control. 2010;21(2):269–74. https://doi.org/10.1007/s10552-009-9458-0.
Global Burden of Disease Cancer C. The global burden of cancer 2013. JAMA Oncol. 2015;1(4):505–27. https://doi.org/10.1001/jamaoncol.2015.0735.
Roshandel G, Boreiri M, Sadjadi A, Malekzadeh R. A diversity of cancer incidence and mortality in West Asian populations. Ann Glob Health. 2014;80(5):346–57. https://doi.org/10.1016/j.aogh.2014.09.012.
Mohagheghi M-A, Mosavi-Jarrahi A, Malekzadeh R, Parkin M. Cancer incidence in Tehran Metropolis: the first report from the Tehran population-based cancer registry, 1998–2001. Arch Iran Med. 12(1):15–23.
Masoompour SM, Yarmohammadi H, Rezaianzadeh A, Lankarani KB. Cancer incidence in southern Iran, 1998–2002: results of population-based cancer registry. Cancer Epidemiol. 2011;35(5):e42–7. https://doi.org/10.1016/j.canep.2011.05.018.
Islami F, Kamangar F, Nasrollahzadeh D, Møller H, Boffetta P, Malekzadeh R. Oesophageal cancer in Golestan Province, a high-incidence area in northern Iran––a review. Eur J Cancer. 2009;45(18):3156–65. https://doi.org/10.1016/j.ejca.2009.09.018.
Islami F, Cao Y, Kamangar F, Nasrollahzadeh D, Marjani H-A, Shakeri R, et al. Reproductive factors and risk of esophageal squamous cell carcinoma in northern Iran: a case–control study in a high-risk area and literature review. Eur J Cancer Prev. 2013;22(5):461–6. https://doi.org/10.1097/CEJ.0b013e32835c7f87.
Islami F, Pourshams A, Nasrollahzadeh D, Kamangar F, Fahimi S, Shakeri R, et al. Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ: Br Med J. 2009;338 https://doi.org/10.1136/bmj.b929.
Shakeri R, Malekzadeh R, Etemadi A, Nasrollahzadeh D, Aghcheli K, Sotoudeh M. Opium: an emerging riskfactor for gastric adenocarcinoma. Int J Cancer. 2013;133(2):455–61.
Fallahzadeh MA, Salehi A, Naghshvarian M, Fallahzadeh MH, Poustchi H, Sepanlou SG, et al. Epidemiologic study of opium use in pars cohort study: a study of 9000 adults in a rural southern area of Iran. Arch Iran Med. 2017;20(4):205–10.
Bhat GA, Shah IA, Rafiq R, Nabi S, Iqbal B, Lone MM, et al. Family history of cancer and the risk of squamous cell carcinoma of oesophagus: a case-control study in Kashmir, India. Br J Cancer. 2015;113(3):524–32. https://doi.org/10.1038/bjc.2015.218.
Islami F, Kamangar F, Nasrollahzadeh D, Aghcheli K, Sotoudeh M, Abedi-Ardekani B, et al. Socio-economic status and oesophageal cancer: results from a population-based case–control study in a high-risk area. Int J Epidemiol. 2009;38(4):978–88. https://doi.org/10.1093/ije/dyp195.
Golozar A, Etemadi A, Kamangar F, Fazeltabar Malekshah A, Islami F, Nasrollahzadeh D, et al. Food preparation methods, drinking water source, and esophageal squamous cell carcinoma in the high-risk area of Golestan, Northeast Iran. Eur J Cancer Prev. 2016;25(2):123–9. https://doi.org/10.1097/cej.0000000000000156.
Emamian MH, Fateh M, Hosseinpoor AR, Alami A, Fotouhi A. Obesity and its socioeconomic determinants in Iran. Econ Hum Biol. 2017;26(Supplement C):144–50. https://doi.org/10.1016/j.ehb.2017.03.005.
Moradzadeh R, Mansournia MA, Baghfalaki T, Ghiasvand R, Noori-Daloii MR, Holakouie-Naieni K. Misclassification adjustment of family history of breast cancer in a case-control study: a Bayesian approach. Asian Pac J Cancer Prev. 2015;16:8221–6.
Acknowledgments
This work was supported by the Islamic Azad University-Sanandaj Branch, Sanandaj, Iran (grant number 1.2926).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This study was conducted in compliance with the provisions of the Helsinki Declaration. The protocol was approved by the Ethics committee of Arak University of Medical Sciences, Arak, Iran, with the ethical code IR.ARAKMU.REC.1394.384.
Conflict of Interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Moradzadeh, R., Golmohammadi, P., Ghaitasi, B. et al. Incidence of Esophageal Cancer in Iran, a Population-Based Study: 2001–2015. J Gastrointest Canc 50, 507–512 (2019). https://doi.org/10.1007/s12029-018-0114-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-018-0114-3